Gimv NV

GIMB

BE0003699130

Investment Management & Fund Operators

Market Closed - Euronext Bruxelles Other stock markets 11:35:05 2024-12-10 am EST			5-day change	1st Jan Change
39.70 ^EUR	+0.63%		+0.38%	-10.38%

Dec. 04	Gimv: acquisition of Nantes-based energy company Tibbloc	CF
Dec. 04	Gimv Buys Majority Stake in Temporary Energy Services Company Tibbloc	MT

Lenaerts NV announced that it has received funding from Gimv NV

December 30, 2022

Lenaerts NV announced that it has received funds in a round of funding in 2022. The transaction included participation from new investor Gimv NV.

Latest news about Gimv NV

Gimv: acquisition of Nantes-based energy company Tibbloc	Dec. 04	CF
Gimv Buys Majority Stake in Temporary Energy Services Company Tibbloc	Dec. 04	MT
Gimv NV, Eric Merilhou, Yann Dauce and the management of Tibbloc acquired an unknown majority stake in Tibbloc from Ciclad, SAS.	Dec. 03	CI
Gimv: focus on 'Made in Germany' with Lupine	Dec. 02	CF
Gimv's Consumer Unit Buys Majority Stake in Germany's Lupine Lighting Systems	Dec. 02	MT
Gimv NV and Wolf D. Koch agreed to acquire an unknown majority stake in Lupine Lighting Systems GmbH from Wolf D. Koch.	Dec. 01	CI
Gimv: majority stake sold in rehaneo	Nov. 20	CF
Gimv Sells Majority Stake in Outpatient Rehabilitation Company	Nov. 20	MT
Fremman Limited agreed to acquire an unknown majority stake in rehaneo GmbH from Gimv NV.	Nov. 19	CI
Gimv NV Reports Earnings Results for the Half Year Ended September 30, 2024	Nov. 19	CI
Kivu Bioscience announced that it has received $92.000004 million in funding from a group of investors	Oct. 27	CI
Gimv Sells United Dutch Breweries to Brouwerij Martens	Oct. 16	MT
The Martens Brewery of Bocholt acquired United Dutch Breweries B.V. from Gimv NV and management.	Oct. 15	CI
Gimv: half of Infravest transferred to WorxInvest	Sep. 20	CF
Belgium's Gimv to Sell Half of Infravest Stake to WorxInvest	Sep. 20	MT
ImmunOs Therapeutics AG announced that it has received $11 million in funding from Gimv NV, Pfizer Venture Investments LLC, Mission BioCapital, LP, BioMedPartners AG, Double Point Ventures, and other investors	Sep. 16	CI
Kivu Bioscience announced that it expects to receive $93.721047 million in funding	Sep. 12	CI
Such a long wait	Sep. 05
Gimv: sale of stake in Mega International	Sep. 05	CF
Belgium's Gimv Divests Stake in Mega International to Bizzdesign	Sep. 05	MT
BiZZdesign BV agreed to acquire MEGA International S.A. from Gimv NV.	Sep. 03	CI
Gimv: share price up after business update	Sep. 03	CF
Gimv: investment in bicycle accessories	Jul. 02	CF
Gimv Takes Stake in Bicycle Components Maker Curana	Jul. 02	MT
Curana Bvba announced that it has received funding from Gimv NV	Jul. 01	CI

Gimv NV is one of the leading investment companies in Belgium. At the end of March 2024, the portfolio had an estimated market value of EUR 1,559 million broken down by type of shares as follows: - investments in unlisted companies (92.9%); - investments in listed companies (4.5%); - other (2.6%). Portfolio breaks down geographically by value as follows: Belgium (31%), Germany/Switzerland/Austria (30%), France (19%), the Netherlands (17%) and RoW (3%).

Employees

Sector

Investment Management & Fund Operators

Calendar

2025-01-21 - Capital Markets Day

More about the company